First Tracks Biotherapeutics (TRAX)
Develops antibody programs for autoimmune and inflammatory diseases.
$45.00
Pre-market−0.28 (−0.62%)
At close$45.28(+9.98%)
Something off on this page? Send us feedback.
EPSReportedEstimate
——————Aug '26Aug '26
Reported——————−$0.95−$0.95
Estimate——————−$0.74−$0.80
Surprise——————−28.4%−18.4%
RevenueReportedEstimate
——————Aug '26Aug '26
Reported————————
Estimate——————$75.0M$75.0M
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.80 | −$0.95 | −18.4% |
| Aug 2026 | −$0.74 | −$0.95 | −28.4% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | −$0.80 | −$0.95 | −18.4% | $75.0M | — | — | −4.6% |
| Aug 11, 2026 | −$0.74 | −$0.95 | −28.4% | $75.0M | — | — | −1.3% |